Skip to content

The Effect of Permissive Hypercapnia on Postoperative Nausea and Vomiting in Laparoscopic Surgery Patients

The Effect of Permissive Hypercapnia on Postoperative Nausea and Vomiting in Laparoscopic Surgery Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096048
Enrollment
Unknown
Registered
2025-01-16
Start date
2024-11-07
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative nausea and vomiting

Interventions

Research group:The respiratory parameters were adjusted during the operation to maintain PaCO2 45 ~ 55mmHg and pH > 7.2
Control group:By adjusting respiratory parameters during operation, PaCO2 was maintained at 35 ~ 45mmHg

Sponsors

The First Affiliated Hospital of Dalian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Female patients who plan to undergo laparoscopic surgery in our hospital; 2. Age 18-65 years old; 3. body mass index (BMI) 18-28kg /m2; 4. American Society of Anesthesiologists (ASA) grades I to III; 5. Non-smokers; 6. Patients who did not take hormones, opioids or antiemetic drugs within 72 hours before surgery.

Exclusion criteria

Exclusion criteria: 1. The patient refused to sign the informed consent; 2. Patients intending to undergo gastrointestinal surgery; 3. Diabetic patients; 4. Patients with a history of motion sickness or PONV before surgery; 5. Those who have gastrointestinal diseases, craniocerebral diseases, otogenic diseases or who have received chemotherapy in the past few weeks; 6. Serious heart, lung, cerebrovascular diseases or liver and kidney function damage; 7. People with serious neurological or mental disorders; 8. Patients with elevated PaCO2 indicated by preoperative blood gas analysis; 9. Inability to understand or use visual analogue scale (VAS) scales and patient controlled intravenous analgesia (PCIA).

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative nausea and vomiting;The severity of postoperative nausea and vomiting;

Secondary

MeasureTime frame
Postoperative adverse events;Wake-up time;

Countries

China

Contacts

Public ContactMiao Zhuang

Dalian Medical University Affiliated First Hospital

sunhe391x@163.com+86 180 9887 6195

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026